Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors

BACKGROUND: Tumor classification based on their predicted responses to kinase inhibitors is a major goal for advancing targeted personalized therapies. Here, we used a phosphoproteomic approach to investigate biological heterogeneity across hematological cancer cell lines including acute myeloid leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Casado, Pedro, Alcolea, Maria P, Iorio, Francesco, Rodríguez-Prados, Juan-Carlos, Vanhaesebroeck, Bart, Saez-Rodriguez, Julio, Joel, Simon, Cutillas, Pedro R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054101/
https://www.ncbi.nlm.nih.gov/pubmed/23628362
http://dx.doi.org/10.1186/gb-2013-14-4-r37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054101/
https://www.ncbi.nlm.nih.gov/pubmed/23628362
http://dx.doi.org/10.1186/gb-2013-14-4-r37

Ejemplares similares